Barclays analyst Matt Miksic raised the firm’s price target on Abbott to $141 from $133 and keeps an Overweight rating on the shares. The analyst views the post-earnings pressure in the stock as unwarranted. The stock is attractive at current levels, backed up by a sum-of-parts analysis, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ABT: